L-708,474: The C5-cyclohexyl analogue of L-365,260, a selective high affinity ligand for the CCKB/gastrin receptor

[1]  A. Kopin,et al.  A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists , 1993, Nature.

[2]  S. Wank,et al.  Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. , 1992, Biochemical and biophysical research communications.

[3]  J Hoflack,et al.  Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. , 1991, Molecular pharmacology.

[4]  J. Mollon.  Hue and the heptahelicals , 1991, Nature.

[5]  C. Dourish,et al.  Cholecystokinin and anxiety. , 1990, Trends in pharmacological sciences.

[6]  R. Chang,et al.  A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. , 1989, European journal of pharmacology.

[7]  B. E. Evans,et al.  Synthesis and resolution of 3-amino-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-ones , 1987 .

[8]  R J Gould,et al.  In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist. , 1987, The Journal of pharmacology and experimental therapeutics.

[9]  M. Beinfeld.  Cholecystokinin in the central nervous system: A minireview , 1983, Neuropeptides.

[10]  T. Petcher,et al.  An opioid benzodiazepine , 1982, Nature.

[11]  J. Hunter,et al.  Rationally designed "dipeptoid" analogues of CCK. alpha-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties. , 1991, Journal of medicinal chemistry.

[12]  A. Nadzan,et al.  Chapter 20. Cholecystokinin Agonists and Antagonists , 1991 .

[13]  B. E. Evans,et al.  Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260. , 1989, Journal of medicinal chemistry.